(Q48588523)

13 February 2018

title

Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships (English)

1 reference

13 February 2018

author name string

Scorza MC

1

1 reference

13 February 2018

Carrau C

2

1 reference

13 February 2018

Silveira R

3

1 reference

13 February 2018

Zapata-Torres G

4

1 reference

13 February 2018

Cassels BK

5

1 reference

13 February 2018

Reyes-Parada M

6

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 December 1997

1 reference

13 February 2018

published in

Biochemical Pharmacology

1 reference

13 February 2018

volume

54

1 reference

13 February 2018

issue

12

1 reference

13 February 2018

page(s)

1361-1369

1 reference

13 February 2018

Substrate-selective monoamine oxidases—inhibitor, tissue, species and functional differences

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Inhibition of monoamine oxidase by amphetamine and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Selective monoamine oxidase inhibitors. 4. 4-Aminophenethylamine derivatives with neuron-selective action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Monoamine oxidase inhibitory effects of some 4-aminophenethylamine derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Inhibition of brain type A monoamine oxidase and 5-hydroxytryptamine uptake by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Selective monoamine oxidase inhibitors. 3. Cyclic compounds related to 4-aminophenethylamine. Preparation and neuron-selective action of some 5-(2-aminoethyl)-2,3-dihydroindoles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Inhibition of monoamine oxidase in 5-hydroxytryptaminergic neurones by substituted p-aminophenylalkylamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Potential psychotomimetics. New bromoalkoxyamphetamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Electrochemical oxidation of methylenedioxyamphetamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Binding of substituted and conformationally restricted derivatives of N-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane at .sigma.-receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

4-Dimethylaminophenethylamine, a sensitive, specific, electrochemically detectable monoamine oxidase-B substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: Drug levels in brain and effects on brain serotonin metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Synthesis, Biological Evaluation and Quantitative Structure Activity Relationship Analysis of Nuclear-substituted Pargylines as Competitive Inhibitors of MAO-A and MAO-B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

A PLS quantitative structure-activity relationship study of some monoamine oxidase inhibitors of the phenyl alkylamine type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Effects of p-chloroamphetamine on brain serotonin neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

Behavioral effects of the putative anxiolytic (+/-)-1-(2,5-dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2) in rats and mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

(+/-)-1-(2,5-Dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2), a novel putative anxiolytic agent lacking affinity for benzodiazepine sites and serotonin-1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900405-X

10.1016/S0006-2952(97)00405-X

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018